Australia - English - Department of Health (Therapeutic Goods Administration)

nature's bio technology pty ltd - ganoderma lucidum, quantity: 50 mg (equivalent: ganoderma lucidum, qty 1 g); thymus vulgaris, quantity: 83.25 mg (equivalent: thymus vulgaris, qty 333 mg); astragalus membranaceus, quantity: 300 mg (equivalent: astragalus membranaceus, qty 3 g); zinc gluconate, quantity: 7.78 mg (equivalent: zinc, qty 1.1 mg); dl-alpha-tocopheryl acetate, quantity: 1.7 mg; retinol palmitate, quantity: 286 microgram (equivalent: vitamin a, qty 156.156 re); selenomethionine, quantity: 30 microgram (equivalent: selenium, qty 12 microgram); calcium ascorbate dihydrate, quantity: 9.68 mg (equivalent: ascorbic acid, qty 8 mg) - tablet, film coated - excipient ingredients: purified water; iron oxide black; dextrin; butylated hydroxytoluene; microcrystalline cellulose; croscarmellose sodium; iron oxide red; maltodextrin; colloidal anhydrous silica; magnesium stearate; sucrose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000; lecithin - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; aids/assists natural body cleansing/detoxification processes ; maintain/support natural body cleansing/detoxification processes ; maintain/support body mucous membrane health ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support immune system health ; enhance/improve/promote immune defence/immunity ; helps enhance/improve/promote immune system function ; maintain/support healthy immune system function ; helps stimulate a healthy immune system response ; soothe/calm the chest ; decrease/reduce excess chest phlegm ; loosen chest phlegm ; decrease/reduce excess mucous ; decrease/reduce/relieve mild upper respiratory tract congestion ; decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; expectorant/clear respiratory tract mucous ; loosen respiratory tract mucous ; relieve symptoms of mild upper respiratory tract infections ; helps reduce occurrence of symptoms of upper respiratory tract infections ; decrease/reduce/relieve cough ; enhance/improve/promote/increase cough productivity ; maintain/support lung health ; maintain/support healthy mucous membranes/mucous tissue of the respiratory tract ; soothe respiratory tract mucous membranes/mucous tissue ; decrease/reduce/relieve throat mucous membrane irritation/inflammation

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - factor viii,von willebrand factor -

United States - English - NLM (National Library of Medicine)

natural creations, inc. - juglans cinerea branch bark/root bark (unii: 48fz1bho18) (juglans cinerea branch bark/root bark - unii:48fz1bho18), potassium iodide (unii: 1c4qk22f9j) (iodide ion - unii:09g4i6v86q), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), mercury (unii: fxs1by2pgl) (mercury - unii:fxs1by2pgl), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), phosphorus (unii: 27ylu75u4w) (phosphoru - juglans cinerea branch bark/root bark 30 [hp_c] in 1 ml - uses: temporarily relieves pustules, dry cracked skin with soreness.** uses: temporarily relieves pustules, dry cracked skin with soreness.**

United States - English - NLM (National Library of Medicine)

fresenius medical care holdings, inc. - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611) - ferric cation 20 mg in 1 ml - venofer is indicated for the treatment of iron deficiency anemia (ida) in patients with chronic kidney disease (ckd). - known hypersensitivity to venofer risk summary published studies on intravenous iron sucrose treatment after the first trimester of pregnancy have not shown adverse maternal or fetal outcomes (see data) . available reports of intravenous iron sucrose use in pregnant women during the first trimester are insufficient to assess the risk of major birth defects and miscarriage. there are risks to the mother and fetus associated with untreated ida in pregnancy as well as risks to the fetus associated with maternal severe hypersensitivity reactions (see clinical considerations) . animal reproduction studies of iron sucrose administered to rats and rabbits during the period of organogenesis at elemental iron doses equivalent to the maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus (see data). the estimated background risk of major birth defects and

United States - English - NLM (National Library of Medicine)

american regent, inc. - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611) - ferric cation 20 mg in 1 ml - venofer is indicated for the treatment of iron deficiency anemia (ida) in patients with chronic kidney disease (ckd). - known hypersensitivity to venofer. risk summary published studies on intravenous iron sucrose treatment after the first trimester of pregnancy have not shown adverse maternal or fetal outcomes (see data) . available reports of intravenous iron sucrose use in pregnant women during the first trimester are insufficient to assess the risk of major birth defects and miscarriage. there are risks to the mother and fetus associated with untreated ida in pregnancy as well as risks to the fetus associated with maternal severe hypersensitivity reactions (see clinical considerations) . animal reproduction studies of iron sucrose administered to rats and rabbits during the period of organogenesis at elemental iron doses equivalent to the maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus (see data). the estimated background risk of major birth defects and

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen (unii: luy6p8763w) (haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen - unii:luy6p8763w) - haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen 1 g in 1 g

United States - English - NLM (National Library of Medicine)

natural creations, inc. - juglans cinerea branch bark/root bark (unii: 48fz1bho18) (juglans cinerea branch bark/root bark - unii:48fz1bho18), potassium iodide (unii: 1c4qk22f9j) (iodide ion - unii:09g4i6v86q), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), mercury (unii: fxs1by2pgl) (mercury - unii:fxs1by2pgl), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), phosphorus (unii: 27ylu75u4w) (phosphoru - juglans cinerea branch bark/root bark 30 [hp_c] in 1 ml - uses: temporarily relieves pustules, skin ulcerations, dry cracked skin with soreness, &/or symptoms related to herpes sores. other information: tamper seal: "sealed for your protection." do not use if seal is broken or missing. uses: temporarily relieves pustules, skin ulcerations, dry cracked skin with soreness, &/or symptoms related to herpes sores.

United States - English - NLM (National Library of Medicine)

l&r distributors - sucrose (unii: c151h8m554) (sucrose - unii:c151h8m554), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn) - upset stomach reliever for relief of nausea due to upset stomach from intestinal flu, stomach flu, and food or drink indiscretions.

United States - English - NLM (National Library of Medicine)

select brand distributors - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - guaifenesin 400 mg - guaifenesin.......................expectorant phenylephrine hcl..............nasal decongestant temporarily relieves symptoms associated with a cough ,the common cold,hay fever or other upper respiratory allergies. ■ helps loosen phlegm (mucus) ■ clear nasal passageways ■ loosens nasal congestion ■ drain bronchial tubes ■ shrinks swollen membranes ■ clears stuffy nose ■ makes coughs more productive ■ this product if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you are uncertain whether your prescription drug contains an maoi, ask a health professional. ■ heart disease ■ high blood pressure ■ thyroid disease ■ diabetes ■ excessive phlegm;mucus ■ difficulty in urination due to an enlarged prostate gland ■ persistent or chronic cough such as occurs with smoking,asthma,chronic bronchitis or emphysema ■ nervousness, dizziness

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - von willebrand factor, quantity: 500 iu; factor viii, quantity: 250 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.